The Enterprise Value as of December 2025 (TTM) for Nabriva Therapeutics plc (NBRV) is -7192677.00

According to Nabriva Therapeutics plc’s latest financial reports and current stock price. The company's current Enterprise Value is -7192677.00. This represents a change of 314.28% compared to the average of -1736187.50 of the last 4 quarters.

Nabriva Therapeutics plc (NBRV) Historical Enterprise Value (quarterly & annually)

How has NBRV Enterprise Value performed in the past?

The mean historical Enterprise Value of Nabriva Therapeutics plc over the last ten years is -32399849.58. The current -7192677.00 Enterprise Value has changed 2.12% with respect to the historical average. Over the past ten years (40 quarters), NBRV's Enterprise Value was at its highest in in the December 2014 quarter at 24.76M. The Enterprise Value was at its lowest in in the September 2015 quarter at -122478481.30.

Nabriva Therapeutics plc (NBRV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nabriva Therapeutics plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nabriva Therapeutics plc (NBRV) Average Enterprise Value

How has NBRV Enterprise Value performed in the past?

The current Enterprise Value of Nabriva Therapeutics plc (NBRV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Nabriva Therapeutics plc (NBRV) Enterprise Value vs. Peers

How is NBRV’s Enterprise Value compared to its peers?

Nabriva Therapeutics plc’s Enterprise Value is less than Aptose Biosciences Inc. (4.06M), less than Gamida Cell Ltd. (40.73M), less than Neuphoria Therapeutics Inc. (-5981497.00), less than TNF Pharmaceuticals, Inc. (8.98M), less than Gritstone bio, Inc. (43.29M), less than Hillstream BioPharma, Inc. (1.93M), greater than ViewRay, Inc. (-44998227.00), less than Altamira Therapeutics Ltd. (384.83K), less than BiondVax Pharmaceuticals Ltd. (23.41M), less than Atreca, Inc. (36.62M),

Build a custom stock screener for Nabriva Therapeutics plc (NBRV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nabriva Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nabriva Therapeutics plc (NBRV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nabriva Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.